Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Short Interest Down 6.0% in January
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) saw a large decrease in short interest in January. As of January 31st, there was short interest totalling 1,100,000 shares, a decrease of 6.0% from the January 15th total of 1,170,000 shares. Approximately 5.0% of the company’s stock are short sold. Based on an average daily volume […]
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) saw a large decrease in short interest in January. As of January 31st, there was short interest totalling 1,100,000 shares, a decrease of 6.0% from the January 15th total of 1,170,000 shares. Approximately 5.0% of the company’s stock are short sold. Based on an average daily volume […]
